Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
avapritinib
3
×
blueprint medicines
boston blog main
cancer
3
×
life sciences
national blog main
biotech
boston
boston top stories
clinical trials
eli lilly
indiana blog main
indiana top stories
national top stories
san francisco blog main
san francisco top stories
aimmune therapeutics
alopecia areata
amarin
andrew berens
arena pharmaceuticals
boehringer ingelheim
boulder/denver blog main
boulder/denver top stories
cadent therapeutics
cancer drugs
cancer immunotherapy
capmatinib
celgene
centers for disease control and prevention
centrexion therapeutics
colucid pharmaceuticals
concert pharmaceuticals
deciphera pharmaceuticals
detroit blog main
detroit top stories
dragonfly therapeutics
esophageal cancer
europe blog main
europe top stories
What
approval
blueprint
cancer
drug
fda
address
announced
approves
arena’s
bio
bounty
carries
certain
chasing
cig
comeback
companies
corner
deadly
deals
deciphera
delivered
designed
expressing
filing
forms
genetic
gi
ipo
latest
life
little
medicine
medicines
moderna’s
morning
number
pass
pharamceuticals
plans
Language
unset
Current search:
avapritinib
×
cancer
×
@xconomy.com
3 years ago
FDA Approves Blueprint Cancer Drug Targeting RET Genetic Signatures
@xconomy.com
4 years ago
Chasing Blueprint, Deciphera Plans FDA Filing for GI Cancer Drug
@xconomy.com
5 years ago
Bio Roundup: Moderna’s IPO, Arena’s Comeback, E-Cig Survey & More